New test to predict Plavix response after mild stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial is testing whether a new blood test can help predict how well Plavix (clopidogrel) works in people who have had a mild stroke or a high-risk mini-stroke (TIA). If the test works, doctors may be able to adjust treatment sooner to prevent another stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had a mild stroke (NIHSS score ≤ 3) or a high-risk mini-stroke (ABCD2 score ≥ 4).
- Your symptoms started within the last 72 hours and you have already started taking Plavix (alone or with aspirin).
- Your stroke was not caused by a heart problem like atrial fibrillation or by a blood clot from elsewhere in the body.
- You do not have severe liver or kidney problems, a bleeding disorder, active ulcers, or a history of easy miscarriage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people who have had a stroke caused by narrowed arteries in the brain and are scheduled for a stent placement. It looks at whether a blood test can help predict who might have another stroke despite taking common blood thinners.
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
This study tests whether doctors can safely reduce the strength of blood-thinning medications after a minor stroke by measuring how well your blood clots. The goal is to find the right dose that protects you without increasing bleeding risk.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.